Bcl-2 is well known as an anti-apoptotic oncogene in lymphomas [73], and this anti-apoptotic function may explain why Bcl-2 positivity has been associated with the chemoresistance [63, 74, 75] and radioresistance [76] of breast cancer cells. This evidence concerns the gene BCL2 and breast carcinoma.